Please assess the completion status of the following clinical trial:

Trial Title: Steroid Administration for Articular Fractures of the Elbow (SAFE Trial)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~• All adults ≥18 years old with an isolated, intra-articular traumatic elbow fracture to be treated at Vanderbilt University Medical Center with operative intervention and a standardized post-operative rehab protocol.~* Intra-articular elbow fracture defined as:~  * Distal humerus~ * Proximal ulna~ * Radial head fracture~ * Combination fracture of two or more of the above~* Radiographs present confirming intra-articular injury~Exclusion Criteria~* Patients with bilateral elbow fractures~* Patients with an altered mental status~* Pregnant~* Allergy or contra-indication to glucocorticoid administration~* Type 1 or Type 2 diabetes~* Pre-injury limitation in elbow range or motion (patient reported)~* Unable to provide consent for themselves

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment Arm (Glucocorticoid) (Type: EXPERIMENTAL): Patients will receive a single intraoperative dose of 10mg of intravenous dexamethasone. Following surgery, the participant will be provided with a 1) six-day oral methylprednisolone taper course.
- Control Arm (Placebo) (Type: PLACEBO_COMPARATOR): Patients will receive a single intraoperative dose of 10 mg of saline. Following surgery, the participant will be provided with a six-day placebo course.

Based on this trial design, predict the completion outcome and termination type (if applicable).